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Abstract
Background: Evidence of benefit for telehealth for chronic conditions is mixed. Two linked randomized controlled trials tested
the Healthlines Service for 2 chronic conditions: depression and high risk of cardiovascular disease (CVD). This new telehealth
service consisted of regular telephone calls from nonclinical, trained health advisers who followed standardized scripts generated
by interactive software. Advisors facilitated self-management by supporting participants to use Web-based resources and helped
to optimize medication, improve treatment adherence, and encourage healthier lifestyles. Participants were recruited from primary
care. The trials identified moderate (for depression) or partial (for CVD risk) effectiveness of the Healthlines Service.
Objective: An embedded qualitative study was undertaken to help explain the results of the 2 trials by exploring mechanisms
of action, context, and implementation of the intervention.
Methods: Qualitative interview study of 21 staff providing usual health care or involved in the intervention and 24 patients
receiving the intervention.
Results: Interviewees described improved outcomes in some patients, which they attributed to the intervention, describing how
components of the model on which the intervention was based helped to achieve benefits. Implementation of the intervention
occurred largely as planned. However, contextual issues in patients’ lives and some problems with implementation may have
reduced the size of effect of the intervention. For depression, patients’ lives and preferences affected engagement with the
intervention: these largely working-age patients had busy and complex lives, which affected their ability to engage, and some
patients preferred a therapist-based approach to the cognitive behavioral therapy on offer. For CVD risk, patients’ motivations
adversely affected the intervention whereby some patients joined the trial for general health improvement or from altruism, rather
than motivation to make lifestyle changes to address their specific risk factors. Implementation was not optimal in the early part
of the CVD risk trial owing to technical difficulties and the need to adapt the intervention for use in practice. For both conditions,
enthusiastic and motivated staff offering continuity of intervention delivery tailored to individual patients’ needs were identified
as important for patient engagement with telehealth; this was not delivered consistently, particularly in the early stages of the
trials. Finally, there was a lack of active engagement from primary care.
Conclusions: The conceptual model was supported and could be used to develop further telehealth interventions for chronic
conditions. It may be possible to increase the effectiveness of this, and similar interventions, by attending to the human as well
as the technical aspects of telehealth: offering it to patients actively wanting the intervention, ensuring continuity of delivery by
enthusiastic and motivated staff, and encouraging active engagement from primary care staff.
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Introduction
The increasing prevalence of chronic conditions presents a
challenge to health systems internationally in terms of the ability
to meet patients’ health care needs. There is interest in the
potential of technology to address this challenge by offering an
alternative to face-to-face care between health care professionals
and patients [1]. Telemedicine or telehealth delivers health care
at a distance using information and communication technologies
for diagnosis, treatment, and prevention of health problems [1].
These technologies can be supported by different types of
clinical and nonclinical staff and thus expand health care
provision and increase access to care. Policy makers worldwide
have enrolled large numbers of patients in telehealth schemes
[1-3] and are evaluating telehealth programs [1,4].
Despite the promotion of telehealth internationally, evidence
of benefit is mixed [5-7]. A large review of the effectiveness of
telehealth for chronic conditions concluded that the evidence
base is weak and inconclusive due to publication bias, short-term
outcome measurement, and a lack of focus on cost-effectiveness
[5]. A review of reviews of telehealth concluded that telehealth
could be effective for the management of some chronic
conditions, but that evidence is mixed with a need for larger
studies [6]. A more recent review of interactive telehealth
concluded that telehealth was effective for some chronic
conditions, specifically heart failure and diabetes, but that
evidence was inconsistent for other conditions [7].
The lack of consistency of the evidence base on telehealth could
reflect a lack of theoretical underpinning for many interventions
or problems with the quality of their evaluation. It has been
recommended that large, rigorous evaluations of any new
interventions are undertaken [8]. Furthermore, process
evaluations undertaken alongside trials of complex interventions
such as telehealth may enable researchers to understand why
interventions succeed or fail by exploring context, mechanisms
of action, and implementation of the intervention [9]. Qualitative
research can contribute to this [10].
Researchers have started to address the need for large, pragmatic
trials of theory-based telehealth for chronic conditions. Two
large, linked, randomized controlled trials (RCTs) of a telehealth
intervention, known as the Healthlines Service, which followed
up patients for a year, focused on depression and on risk factors
for cardiovascular disease (CVD) [11]. The trial targeting
depression identified a moderate clinical benefit [12], whereas
the trial focusing on reducing risk factors for CVD identified a
partial effect; that is, improvement in some individual risk
factors but not overall CVD risk score [13]. An embedded
qualitative study was undertaken with both these trials with the
aim of explaining the results of the trials [11]. In this paper, we
report this embedded qualitative study to explore why the trials
showed modest effects only and then discuss the implications
of this for future use and evaluation of this type of telehealth
intervention.
Methods
The telehealth intervention is described in Textbox 1. The 2
RCTs are described in Textbox 2.
Textbox 1. The intervention
The content and delivery of the Healthlines Service was underpinned by a conceptual model called the TElehealth in CHronic disease (TECH) model
[14]. This model was constructed by the research team based on an extensive review of quantitative and qualitative evidence, a qualitative interview
study with patients and staff experienced with telehealth or with chronic conditions [15] and a postal survey of patients’ levels of interest in different
forms of telehealth [16]. The TECH model builds on the Chronic Care Model [17] and proposes that telehealth interventions are most likely to be
effective and acceptable if they address (1) engagement of patients and health professionals; (2) effective chronic disease management (including
self-management, optimization of treatment, care coordination); (3) partnership between providers; and (4) patient and health system context. This
model was used to design a telehealth intervention for 2 exemplar chronic conditions: depression and raised CVD risk.
The Healthlines Service was based on regular telephone calls over a 12-month period from a nonclinical health information advisor (HIA). The content
of the calls was guided by scripts within computer software designed for the study. The HIAs also used motivational interviewing skills to encourage
behavior change and improve self-management. Patients were encouraged to identify goals and then offered links to information about quality-assessed
resources on the Internet. Some aspects of the intervention were condition specific. For patients with depression, the intervention included book-based
or computerized cognitive behavioral therapy and access to a Web-based mental health network (Big White Wall). For patients with raised CVD risk,
the intervention included blood pressure self-monitoring using loaned blood pressure monitors with automated feedback via a Web portal and advice
about diet, exercise, and smoking cessation. For both conditions, patients’ use of medication was reviewed by the HIA. Problems with medication
adherence were addressed, where patients were not being treated in accordance with national guidelines; a treatment recommendation was sent to their
general practitioner and copied to the Web portal where the patient could view it. The intervention was designed to complement primary care delivered
in general practice. The intervention was delivered by NHS Direct, which was a national telephone-based service at the time of the study. The staff
members delivering the intervention were experienced HIAs who were given additional training to deliver the Healthlines Service.
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Textbox 2. The trials
The Healthlines Service was tested in 2 linked, pragmatic randomized controlled trials comparing the intervention plus usual care versus usual care
alone. Usual care for depression was attendance at general practice, including use of medication and possible referral to psychological services. Usual
care for raised CVD risk was attendance at general practice where patients might receive blood pressure monitoring, medication, and lifestyle advice.
The trials were undertaken with adults with depression or raised CVD risk recruited from 43 general practices in 3 areas of England. Both trials were
powered to detect odds ratios of 1.7 with 80% power [11]. In total, 609 patients were recruited to the depression trial. The primary outcome was
response to treatment measured using the Patient Health Questionnaire (PHQ-9) [18] and defined as a reduction ≥5 points and score <10 after 4 months.
The treatment response was higher in the intervention group than in the control group (27% (68/255) vs 19% (50/270), odds ratio=1.7 (95% CI 1.1-2.5;
P=.02). Twenty-five percent (78/307) of patients received little or none of the intervention [12], which is a similar rate to other pragmatic trials of
telehealth for depression.
Overall, 641 people were recruited to the CVD risk trial. The primary outcome was response to treatment defined as maintenance or reduction in
10-year risk of CVD (measured by QRISK2 score [19]) after 12 months. Participants receiving the intervention had a modest response to treatment
compared with those receiving usual care (50% (148/295) vs 43% (124/291), respectively; adjusted odds ratio 1.3; 95% CI 1.0-1.9). The intervention
was associated with reductions in blood pressure (difference in mean systolic -2.7 mm Hg (95% CI -4.7 to -0.6)) and weight (-1.0 kg (95% CI -1.8 to
-0.3)) but not in cholesterol or smoking status. Eight percent (26/325) of intervention participants received little or none of the intervention, and a
third (103/325) received the full course of intended telephone encounters over the course of a year [13].
We undertook a qualitative interview study alongside the 2 trials
to explain the results of the trials. We planned to interview 3
groups who could reflect on the intervention: primary care staff
working in collaboration with the intervention who could offer
perspectives on its feasibility and acceptability to primary care;
staff from the organization delivering the intervention (NHS
Direct) who could offer perspectives on feasibility; and patients
who had experienced the intervention who could reflect on its
acceptability. We chose to use the data collection method of
interviews because they allow in-depth exploration of
individuals’ perceptions.
Sampling
For the first group (primary care staff), we planned to sample
6 general practices, selected to include practices with populations
from varying levels of deprivation. We had to widen our original
sample from 6 to 13 general practices because it proved difficult
to recruit sufficient numbers of primary care staff from the
original set of practices. Within the 13 practices, we sampled
purposively to reflect the range of relevant professionals offering
primary health care to participants within the intervention arm
of the trial: general practitioners (GPs) and practice nurses or
health care assistants.
For the second group (NHS Direct staff), we sampled staff
purposively to include those delivering the intervention to
participants (Health Information Advisors—HIAs), those
offering technical expertise for the intervention, and those
involved in team and strategic management.
For the third group (patients), we first sampled patients
purposively from the intervention arm of the trials to ensure
half of interviewees were in the depression trial and half in the
CVD risk trial. Next, we used maximum variation sampling so
that patients were interviewed who differed in terms of gender,
age, and levels of depression or types of CVD risk factors. As
a large proportion of patients using the intervention for
depression used little or none of the intervention (25% in
depression trial vs 8% in CVD risk trial), we also interviewed
some patients who had withdrawn from the depression
intervention.
Data Collection
For primary care staff, we wrote to GPs and practice nurses in
participating practices asking for consent for an interview. We
interviewed primary care staff at different stages of the trial
period to obtain a mix of views at an early and later stage of the
intervention delivery. Interviews took place face to face at their
workplace or by telephone if this was more convenient.
For NHS Direct staff, we approached senior managers to identify
relevant staff. We interviewed staff in July 2013, around 12
months after the first depression participant was randomized
and 8 months after the first CVD risk participant was
randomized. This allowed staff to reflect on both the early and
later stages of intervention delivery.
For patients, we contacted those recruited to the intervention
arm of the trials who had consented to participate in the
interview study during the trial recruitment process. We
interviewed these patients after at least 4 months (depression)
or 6 months (CVD risk) of experiencing the intervention to
allow us to obtain reflections on different stages of their care.
This was after the primary outcome measure had been collected
in the depression trial (4 months) and after the first collection
of follow-up outcome data (at 6 months) in the CVD risk trial.
Patients who had withdrawn from the intervention were
interviewed within 5 months of recruitment. Face-to-face
interviews with patients took place at their home or an
alternative venue, depending on their preference.
SJD undertook most of the interviews, with support from AF
and KH. We obtained written informed consent from all
interviewees. Regardless of interviewee type, the focus of the
interviews was on the intervention. We asked about its perceived
utility, problems arising, and issues that enhanced or hindered
its operation in practice. In addition, we asked about the
components of the conceptual model underlying the intervention:
engagement, promoting self-management, treatment
optimization, care coordination, partnership, and context.
Interviews lasted on average 45 minutes for staff, ranging from
16 to 88 minutes, and 58 minutes for patients, ranging from 21
to 124 minutes.
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Analysis
Interviews were digitally recorded and transcribed verbatim.
The framework approach was used to analyze the data [20]. We
read some transcripts from each type of interviewee for
familiarization (stage 1 of framework analysis). We constructed
a thematic framework based on reading these transcripts and
the functions of context, mechanisms of action, and
implementation important to process evaluations [9] (stage 2
of framework analysis). As this qualitative study was embedded
within RCTs, we supplemented this approach with a framework
of the use of qualitative research with trials [10]. This permitted
further exploration of themes concerning the trial, outcomes,
and the health conditions under study. Subthemes of the theme
“mechanisms of action” were informed by the components of
the TElehealth in CHronic disease (TECH) model: engagement,
promoting self-management, treatment optimization, care
coordination, partnership, and context [14].
SJD coded all transcripts to the thematic framework, adding
emerging subthemes throughout this process (stage 3 of
framework analysis). SJD, AOC, AF, and KH then read the text
within each subtheme, paying attention to which interviewees
contributed to each subtheme. The final stage of the framework
approach—“mapping and interpretation”—involved
consideration of relationships between themes and subthemes.
As recommended, the analysis was undertaken before any team
member knowing the outcomes of the trials [21]. Findings of
the qualitative study were discussed among the research team
in September 2014 before the trial results were known. We
suggested in our conclusions from this analysis that the
intervention would be effective because there was evidence
within our data that components of the conceptual model helped
some patients in both trials, and the intervention was
implemented largely as planned. We also suggested that the
complexity of patients’ lives and how the intervention was
implemented appeared to diminish its impact. Paying attention
to the balance of issues, we predicted a small-to-moderate
benefit for each trial. In a second stage of analysis, after the trial
outcomes were known in December 2014, we used the findings
of this qualitative work to help explain the results of the trials.
This involved focusing on the themes we considered to be most
relevant to the research question of why this intervention had
produced a modest effect, while taking care to acknowledge the
uncertainties around our explanation.
The trials and qualitative study were approved by the National
Research Ethics Service Committee South West—Frenchay
(reference 12/SW/0009) and had the following trial registrations:
ISRCTN14172341 (depression) and ISRCTN27508731 (CVD
risk).
Results
Description of Participants
We undertook 45 interviews in total, with 21 staff and 24
patients.
Staff
We interviewed 6 GPs, 5 practice nurses, 1 health care assistant,
and 1 practice-based research nurse (13 in total) from 13 of the
general practices that had participated in the trials. We
approached practice staff who had been involved to some extent
in the trials, for example, GPs who had screened lists of potential
trial participants before recruitment. From a total of 24 primary
care staff approached for interview, 7 GPs and 4 practice nurses
declined primarily because they did not feel they had anything
to say about the intervention.
We interviewed 8 staff from NHS Direct. This included 4 HIAs
who had delivered the intervention for varying lengths of time.
Two had worked in the Healthlines Service from the beginning,
1 for a few months, and 1 had been in post for a month at the
time of the interview. We also interviewed a strategic manager
who had been involved in leading the intervention development,
a technical manager who had helped to develop the intervention,
a supervisor of the HIAs and a team manager from the wider
organization who was not directly involved with the intervention
but who managed the HIAs as part of larger team. This latter
interview was undertaken to explore the wider organizational
context in which the intervention was delivered.
Patients
We approached 16 depression and 20 CVD risk trial participants
to obtain 12 interviews with each group. Patients declined to
participate because they said they were not interested (n=6),
were too busy (n=3), could not be contacted (n=1), or did not
attend the arranged interview (n=2).
Interviewees participating in the depression trial were
interviewed a median of 8 months after randomization, varying
between 5 and 10 months. There were 7 women, they were all
white, and mainly middle-aged (age range 30-66 years). This
generally reflected the demographics of participants in the
depression trial. According to the baseline PHQ-9 classifications,
1 interviewee had severe depression, 4 interviewees had
moderately severe depression, and the remainder had moderate
depression. Four interviewees had formally withdrawn from
using the intervention at the time of the interview.
CVD risk interviewees were interviewed a median of 8 months
after randomization, varying between 3 and 11 months. They
were mainly men (n=9), all white, and all older (age range 62-75
years). This demographic mix was largely in line with the
participants in the CVD risk trial. They had a mix of CVD risk
factors at baseline: 2 smoked, 9 had a body mass index (BMI)
≥ 30, and 8 had systolic blood pressure ≥ 140. Eight were on
blood pressure–lowering medication. The CVD risk score
(QRISK2) was high for all interviewees (as that was an inclusion
criteria for the trial), ranging between 21% and 58%; 3 had a
score higher than 45%. None of the interviewees had formally
withdrawn from using the intervention at the time of the
interview.
Overview of Findings
The findings are presented using the framework of mechanisms
of action, context, and implementation. We show that
interviewees perceived that the intervention was useful for some
patients and described aspects of the intervention that they
valued. However, contextual issues and problems with
implementation negatively affected the impact of the
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intervention. Quotes are accompanied by labels showing the
type of staff or characteristics of patients.
Mechanisms of Action
Perceptions That the Intervention Was Useful for Some
Patients
Interviewees perceived that the intervention had improved the
health of some patients. First, staff delivering the intervention
described individual patients reporting improved mood and
weight loss. They did not describe the characteristics of these
patients, but, instead, described the characteristics of patients
who they perceived were not being helped by the intervention
(see the following section). Second, some of the patients
interviewed reported improvements in health, which they
associated with the intervention. Among the patients in the
depression trial, 6 described benefits such as feeling more
positive because they had been shown ways to cope, had learned
to share problems with their family, felt listened to, or felt that
someone cared about them:
what I needed was a way of dealing with the great
sadnesses and a way of coming to terms with it, and
I think I have got that from [pause], from The
Healthlines Study” [Dep 8, female, aged 66, with
moderate depression at baseline]
Nine of the twelve CVD risk interviewees had a BMI of 30 or
over at baseline. Three of these reported weight loss, which they
attributed to the intervention. They were delighted with the
amount of weight they had lost since joining the study and
described other positive consequences, including reduced blood
pressure, ability to walk more easily, and having more energy.
Some CVD risk interviewees reported making lifestyle changes
that could affect CVD risk factors, such as exercising more,
eating more healthily, and reducing alcohol intake. Four of the
eight interviewees with high blood pressure at baseline (systolic
above 140 mm Hg) reported lowered blood pressure, and another
reported reduced use of blood pressure medication related to
the intervention. Improvements in blood pressure were attributed
to weight loss or introduction of blood pressure medication:
Interviewer: You have got high blood pressure I am presuming?
CVD participant: Not anymore.
Interviewer: Not anymore, good (laugh)
CVD participant: Mainly thanks to this system [CVD
risk 8, male, aged 70, with high blood pressure at
baseline]
Aspects of the Intervention Valued by Staff and Patients
When asked about the different components of the intervention,
interviewees tended to describe their value and how they helped
to improve health. That is, there was support for the conceptual
model on which the intervention was based. For example, both
the HIAs delivering the intervention and patients receiving it
described the necessity and value of different aspects of the
intervention aimed at encouraging patient engagement. This
included the technical support for patients, which helped them
to use computer-based aspects of the intervention, the continuity
of contact with the same HIA, which helped to build rapport
with patients, and enthusiastic and motivated HIAs who made
the effort to tailor the intervention to patients’ needs:
it has been good to build up some kind of relationship
[CVD risk 11, female, aged 49 years, overweight at
baseline]
There was also support for the value of the self-management
aspect of the intervention. Most of the patients we interviewed
described how the intervention helped them to develop
self-management skills through raising awareness of their health
problems and educating them about ways of dealing with those
problems. As 1 patient put it, the intervention was about
helping myself to help myself [Dep 2, male, aged 60
years, with moderately severe depression at baseline.]
I think it makes people realize that there are things
that you can do on a day to day basis […] to bring
[their blood pressure] down, if they are checking it
that regularly for a purpose. You know, I went out for
a walk this morning and my blood pressure was really
good today, and things like that. It makes it very
obvious in black and white right in front of them that
the days when they are doing things, and being a bit
more well-behaved if you like, that it does make a
difference. [Practice Nurse 113]
and then it just gives them something to work on and
I make it clear to them all that they have to do the
hard work themselves if they want to reach their
target. And 8 times out of 10 next time I speak to them
they have done it or the first thing they say to me is
“well I have been eating off a smaller plate” and it
is really nice to hear that. [Health Information
Advisor 2]
Finally, there was some evidence of medication optimization
occurring. Some patients receiving the depression intervention
were on antidepressants, and some CVD risk participants were
on blood pressure medication and statins. Interviewees reported
that the intervention impacted medication taking through HIAs
prompting patients to discuss medication with their GP or
through letters directly from HIA s to GPs.
Context
Individual Context: Lack of Fit With Perceived Need
A key contextual issue, which may have impacted the
effectiveness of the intervention, was patients’ desire to improve
their health. Patients with depression and primary care staff
reported long waits for access to usual care services such as
counseling and cognitive behavioral therapy. Patients with CVD
risk factors wanted to improve their health, and some of those
who wanted to improve their lifestyle perceived a lack of advice
about how to do this, although the practice nurses we
interviewed said they offered this service.
However, there were indications that some patients did not
understand what the intervention entailed when they signed up
to join the trial and, in fact, had no interest in what was on offer
once they had started the intervention. Some patients in the
depression trial described the intervention as too superficial,
not giving access to a therapist, or the same as previous
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treatments because they had already tried cognitive behavioral
therapy.
Some patients in the CVD risk trial reported low motivation to
change their lifestyle; they had been interested generally in
improving their health without necessarily understanding that
this would entail them making lifestyle changes or had joined
the study for altruistic reasons in terms of helping others through
participating in research:
and, I thought, well it will help me, but it might help
somebody else, that is the reason I had a go [CVD
risk 7, male, aged 74 years, with high blood pressure
at baseline]
Other patients in the CVD risk trial had no intention of
addressing a key CVD risk factor that led to their eligibility for
the trial. In particular, 2 of our CVD risk interviewees were
smokers at baseline. Both these reported no success with
smoking cessation because they did not want to stop smoking:
do not bother, I smoke [CVD risk 1, male, aged 62
years, smoker with high blood pressure at baseline.]
Health Information Advisors noted that few patients had reported
giving up or cutting down smoking and that this was a difficult
lifestyle issue to have an impact on. The staff we interviewed
believed that if intrinsic motivation to change was absent, then
patients, particularly those in the CVD risk trial, would find it
difficult to make the necessary lifestyle changes in the timeframe
in which the intervention was offered.
Individual Context: Lack of Fit With Patients’ Lives
Patients in the depression trial tended to be of working age,
whereas those in the CVD risk trial tended to be retired. These
younger patients with depression were described by HIAs as
too busy due to childcare and employment to engage with key
aspects of the intervention such as the telephone calls and
homework for the cognitive behavioral therapy. The HIAs
wondered whether lack of engagement was due to their
depression and their busy lives. They felt that those who did
complete the cognitive behavioral therapy course obtained
benefit from it, and so they wanted the inclusion criteria for the
trial to focus on those who were really committed to making
changes and engaging with the intervention:
The depression ones, a large, it seems to be a lot, to
me, younger people, a lot more women, not all but
they are rushing around, they do not have time, they
forget they have got appointments, and whether it is
part of depression or not I do not know, but they do
not often, they do not answer the phone [Health
Information Advisor 1]
Some interviewees from the depression trial described serious
ongoing life events such as the threat of losing disability and
unemployment benefits, physical illnesses, or coping with family
members and friends who were very ill or depressed. These
issues caused stress on top of the depression, making
engagement with the intervention difficult. According to the
HIAs in our study, life events preventing engagement with the
intervention appeared to be less of an issue for CVD risk
patients. Our interviewees with CVD risk factors did not offer
the same description of complex lives as our interviewees with
depression. The level of complexity of patients’ lives may have
been related to age because the patients in the CVD risk trial
were older and many were retired. Only 1 of the CVD risk
interviewees was still in full-time paid employment, and this
interviewee did report finding it difficult to fit the intervention
into their life.
Research Context: A Randomized Controlled Trial
The intervention was offered in the context of an RCT. The
intervention for depression was ready for use at the beginning
of the trial and needed little or no adaptation during the trial.
However, interviewees from NHS Direct discussed delays in
starting the CVD risk intervention at the beginning of the trial
due to a number of technical problems with the intervention.
This resulted in some patients waiting for several months
between randomization and receiving the intervention. As
specified in the trial protocol, the primary outcome of the CVD
risk trial was measured 12 months after randomization. This
resulted in measurement of 12-month outcomes before some
patients had completed the intervention, which may have
reduced the measured effect of the intervention for CVD risk.
Implementation of the Intervention
When we asked the 3 groups of interviewees about different
components of the intervention, they not only described the
value of these components (see previous sections) but also
described how they occurred in practice. With the exception of
3 issues (described in the following sections), their descriptions
aligned with the planned implementation of the Healthlines
Service.
Continuity of Enthusiastic and Motivated Health
Information Advisors
Continuity of care—ensuring the same HIAs talked to the same
patient throughout their care—was one of the ways in which
the intervention delivered the patient engagement component
of the TECH conceptual model. This appeared to be very
important to some patients we interviewed and was
compromised in the early months of implementation.
Interviewees from NHS Direct described how, during the earlier
months of the intervention, they tested out a model of using
staff part-time in the Healthlines Service and part-time in the
wider organization. This made it difficult for the same HIA to
contact the same patients and also caused challenges for HIAs
trying to learn to use a technically complex intervention. It was
also compounded by large numbers of patients entering the
CVD risk at the same time. This lack of continuity compromised
the ability of HIAs to actively tailor the intervention to different
patients. As the intervention progressed, NHS Direct changed
the model of provision to a small dedicated team of staff who
were enthusiastic about the intervention and felt motivated to
help patients to improve their health. The HIAs we interviewed
were part of this dedicated team and described how they placed
emphasis on providing continuity of care and tailoring the
intervention to the needs of individual patients. However, they
also described how continuity of care could not be fully
delivered even in the later stages because the small team
sometimes struggled to cover sickness absence and holidays
while still providing appointments that suited patients.
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The variation in implementation was evident in patients’
descriptions of their experiences. Some of the patients we
interviewed appreciated the relationship they had built up with
an HIA, feeling listened to and cared for. Others described HIAs
as “going through the motions,” rather than attempting to tailor
the intervention:
because the spiel was exactly the same [CVD risk 10,
male, aged 71 years, with high blood pressure at
baseline.]
This latter group struggled to engage with the intervention.
Indeed, 3 of the interviewees in the depression trial who
expressed concern about a protocoled approach had withdrawn
from the intervention.
Modification of Intervention Delivery During the Trial
NHS Direct staff described how continuing technical difficulties
had to be sorted out during the early weeks of using the
intervention for CVD risk. Health Information Advisors
explained how they had to learn to make the software work in
the context of an ongoing conversation with a patient, modifying
the flow of the scripts that were built into the intervention to
reduce repetition for patients. They also described how they
made notes about patients outside the computerized system to
help them set and monitor plans for patients.
Collaboration With Primary Care
The primary care staff we interviewed had little to say about
specific aspects of the intervention. Health Information Advisors
and patients described how GPs responded to prompts to consult
with patients or change medication but also described how they
did not take an interest in patients’ experiences of the
intervention or proactively contact the Healthlines Service about
individual patients. There was also some evidence that
communication between primary care and HIAs did not always
reach the level of partnership intended by the conceptual model,
which could cause confusion for some patients. For example,
GPs did not necessarily agree with advice from the intervention,
which was based on national guidelines:
there was this one particular patient who was
constantly being, it was being suggested that he be
reviewed by the GP. And the GP was reviewing him,
but it was still the same, you know, it was a bit, you
know, flogging a bit of a dead horse really, because
she was, the GP was very happy with the blood
pressure. Healthlines Study staff were saying, oh, no,
no, no you need to go and see the GP […] and of
course the patient is the one caught in the middle
[Practice Nurse 111]
Discussion
Principal Findings
The interviewees described improved outcomes in some patients
receiving the intervention. They attributed these improvements
to the intervention, describing how components of the
conceptual model on which the intervention was based helped
to achieve benefit. Aspects of the intervention addressing patient
engagement, self-management, and medication optimization
were valued. Implementation of the intervention occurred largely
as planned. However, problems related to context and
implementation may have reduced the size of effect. For
depression, the context of patients’ lives was often complex,
resulting in these working-age patients sometimes being unable
to engage with the intervention. Some patients also wanted a
more therapist-based approach rather than the cognitive
behavioral therapy on offer. For CVD risk, contextual issues
included some patients joining the trial in the hope of improving
their health generally, or altruistically helping with research,
rather than being motivated to make lifestyle changes to address
their specific risk factors. In addition, implementation was not
optimal in the early part of the CVD risk trial as technical
difficulties with the intervention were addressed and staff
delivering the intervention adapted it for use in practice. For
both conditions, enthusiastic and motivated staff members
offering continuity of intervention delivery tailored to individual
patients’ needs were identified as important for patient
engagement with telehealth, but this was not delivered
consistently, particularly in the early stages of the trials. Finally,
there was a lack of active engagement with the intervention
from GPs in primary care. Although some of these issues related
to the technological aspects of the intervention, most of them
are related to human issues—the complexity of patients’ lives
and the need for skillful human support to complement the
technology.
Strengths and Limitations
One key strength of this qualitative study was the inclusion of
interviews with a wide range of stakeholders: staff offering
primary care to patients, managers, and frontline staff delivering
the intervention and patients who had used the intervention and
those who had withdrawn from it. This greatly improved our
understanding of the trial results and provided support for the
use of the TECH conceptual model to underpin these kinds of
interventions. There were 4 limitations. First, we could have
used nonparticipant observation in combination with the
interviews, such as listening to telephone calls and observing
HIAs in their daily work, which may have helped to further
understand implementation of the intervention. Second, although
we felt that we achieved data saturation at the data collection
stage for most of the groups we targeted, this was not the case
for participants in the CVD risk trial because of the range of
risk factors they had. Third, inclusion of other groups may have
helped to further understand the intervention; in particular, HIAs
who had left the service and patients in the control arm of the
trials. Finally, we completed our data collection before the end
of the intervention. The organizational context in which the
intervention was delivered changed toward the end of
intervention delivery. NHS Direct ceased to operate toward the
end of the trials, although the intervention continued to be
offered by the same HIAs working for a different organization.
During the change in the organization hosting the service, there
was a pause in service delivery for some patients, and this might
have affected their engagement with the intervention. However,
we did not have data from those delivering or receiving the
intervention during or after this change.
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Comparison With Prior Work
Some patients in the trials did not engage with the intervention:
25% of patients in the depression trial and 8% of patients in the
CVD risk trial used little or none of the intervention [12,13].
These rates were smaller than a trial of a Web-based program
for reducing CVD risk where almost half of the intervention
users had dropped out at 12 months [22]. Interestingly, the
qualitative research undertaken alongside that trial recommended
the addition of human interaction to motivate and engage
patients. Our qualitative study identified that motivated staff
could enhance patient engagement, and that engagement was
also dependent on human factors related to the patients. It
identified that patients wanted help with their health, but not
necessarily the intervention on offer, or did not see the
intervention as a priority in their complex or busy lives. This
finding is similar to a systematic review of computerized
cognitive behavioral therapy—a core component of our
intervention for depression—which identified that a median of
56% participants completed a full course and that personal
circumstance was more commonly cited as the cause for
noncompletion than difficulties with the technology or social
background [23]. We know that a large proportion (82%) of
invited patients chose not to participate in our trials in the first
place [24]. Among those actively declining participation (rather
than not replying to the trial invite), common reasons given
were that they were too busy or they were not interested in the
research. It was also the case that some patients agreed to
participate who did not want the intervention on offer or whose
lives were too complex to make use of it. Although efforts were
made to communicate to potential participants in advance about
what the intervention entailed, it is possible that the nature of
the intervention was not described clearly enough and was
misunderstood, or that participants held expectations of the
intervention that differed from their experience. These patients
might have declined to take part in the trial if they had known
more about the content of the intervention and the efforts
required of them.
Researchers are beginning to test ways of increasing the
acceptance of Internet-based mental health interventions using
an informational video [25]. This type of video may also be
useful when recruiting patients for trials of telehealth
interventions to help them make informed choices about
participation. For example, people who smoke and do not want
to stop might decline to participate if they understand that a key
focus on the intervention is to help them reduce this risk factor.
This may reflect the real world more because, in practice,
patients tend to access smoking cessation services if motivated
to stop smoking. It is possible that a future trial with more
emphasis on communicating the content of the intervention,
and the efforts required by patients to obtain benefit, might
result in larger effect sizes than seen here.
The importance of the human aspect of telehealth, in terms of
who delivers the intervention and how, was evident from these
interviews. This “personal context” of factors, related to the
practitioners involved, in terms of their perceptions of the
relevance of and interest in the intervention, their skills, and
their motivation has been identified as a type of context affecting
how interventions work [26]. In our study, this personal context
of motivated HIAs appeared to facilitate patient engagement
with the intervention through both developing rapport and
tailoring the intervention. These 2 issues have been identified
as mechanisms of action of telehealth for chronic conditions
[27]. Other researchers have also identified the importance of
continuity of the person delivering telehealth and their level of
motivation during delivery [23,28-30]. This has also been
identified as important for the self-management of chronic
conditions more generally. For example, a recent systematic
review of interventions for the self-management of asthma
identified the importance of actively engaging patients and
having motivated professionals delivering interventions [31].
This focus on the importance of motivated humans delivering
telehealth has not been identified consistently. For example,
qualitative research alongside an RCT of an educational
Web-based tool to prevent problems in young people whose
parents had mental health problems identified technical problems
as the key barrier [32].
The lack of proactive engagement with the intervention from
primary care was perhaps not too surprising given earlier
interviews with practice nurses and GPs before developing the
intervention [15]. These health professionals were ambivalent
and often skeptical about the contribution of telehealth to the
care of chronic conditions. The conclusion of this earlier
research was that there was work to be done in terms of helping
primary care health professionals to understand the changes in
roles and new ways of working necessary to facilitate the
introduction and integration of telehealth innovations into their
services. Our conclusions after delivery of the intervention were
similar, in that there is a need to develop better strategies for
primary care engagement with telehealth. This lack of primary
care engagement with interventions aimed at chronic conditions
is not specific to telehealth interventions [33].
Implications
When delivering this or similar interventions in the real world,
service providers may wish to consider communicating the
content of the intervention clearly to prospective users and the
amount of time and effort required by them to obtain benefit.
They may also wish to ensure the service is provided by
motivated staff who can offer continuity of care and tailor the
intervention to patients’ needs. Given the lack of engagement
from primary care, it may also be helpful for future interventions
to try to develop better strategies for primary care engagement
that also take into consideration the heavy workload in general
practice in the United Kingdom currently. These actions may
increase the effect of this or similar interventions in the future.
There are also implications for the treatment of other chronic
conditions. The conceptual model for the intervention was
supported by this qualitative research, and so could be used to
develop further interventions tailored for different conditions.
These interventions would have to undergo rigorous evaluation
in RCTs. Finally, there is a methodological implication for
trialists. Due to technical problems and delays, some aspects of
the intervention were not fully functional during the early
months of the trials, particularly for CVD risk. The possible
implications of this are that participants in the early stage of the
trials may have received an underdeveloped intervention.
Feasibility testing before a full evaluation is an important aspect
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of the evaluation of complex interventions [34], although finding
sufficient resources to do so within a fixed research timeline
and budget when the problems cannot necessarily be anticipated
in advance may be challenging.
Conclusions
This qualitative research helped to explain why the outcomes
of 2 linked trials were modest. The conceptual model of the
intervention was supported and could be used to develop further
telehealth interventions for chronic conditions. It may be
possible to increase the effectiveness of this, and similar
interventions, by attending to the human and the technical
aspects of telehealth: offering it to patients actively wanting the
intervention, ensuring continuity of delivery by enthusiastic and
motivated staff, and encouraging active engagement from
primary care.
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